Impact Biomedical Inc.IBO
Price (close)
$5.65
Market cap
$48.3M
P/E
61.2x
Revenue (TTM)
$35,000
Net income
$789,000
Dividend yield
—
1-year total return
-30.9%
Net margin
2254.3%
Revenue growth
—
Debt / equity
—
What Impact Biomedical Inc. does.
or the “Company”) discovers, confirms, and patents unique science and technologies which can be developed into new offerings
in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other
leveraging technology and new science with strategic partnerships, we provide advances in biopharmaceuticals, over the counter direct
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $50,000 | — | — | $32,000 |
| Net income | — | -$7.3M | -$4.3M | -$24.7M | -$11.8M |
More on IBO.
- Impact Biomedical Inc. summary
- Impact Biomedical Inc. financial statements
- Impact Biomedical Inc. key metrics
- Impact Biomedical Inc. health scores and style box
- Impact Biomedical Inc. earnings
- Impact Biomedical Inc. dividends
- Impact Biomedical Inc. valuation
- Impact Biomedical Inc. ownership and insiders
- Impact Biomedical Inc. peers
Figures from Impact Biomedical Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.